Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether
- 31 October 1985
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 10 (2), 69-75
- https://doi.org/10.1016/0162-3109(85)90031-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- Characteristics of the binding of platelet-activating factor to platelets of different animal speciesEuropean Journal of Pharmacology, 1984
- Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytesImmunopharmacology, 1983
- Platelet-activating factor: An effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouseImmunopharmacology, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanismImmunopharmacology, 1982
- Inhibition of phospholipid methyltransferase during zymosan induced secretion of platelet-activating factor in human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1981
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966